Ongoing Responsibilities. In connection with the United States IND, an annual report is due in ***. The data cut-off for this report is ***. In order to allow for a smooth transitioning of responsibility regarding this report: (a) after the Effective Date, PFIZER shall continue to run the clinical safety tables for this report, at its cost; (b) LICENSEE shall take responsibility for drafting such annual report and submitting it to the FDA, and (c) PFIZER shall provide Consulting Services for input and review on such annual report as may be requested by LICENSEE according to the agreement on Consulting Services described in Section 1.1.3 of this Schedule B.
Appears in 2 contracts
Sources: License Agreement (Clovis Oncology, Inc.), License Agreement (Clovis Oncology, Inc.)